Yutaka Niihara is CEO & Chairman +1 at Emmaus Life Sciences, Inc. (EMMA). They have made 131 open-market trades across 2 companies since 2016, most recently 2022-11-30.
CIK 0001517691
131 open-market purchases totalling $2.6M since 2016, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| EMMA | 11,990,757 | $33.2M |
| PrivateUnlisted | 10,000 | — |
| Total | $33.2M |
Shares reported on the most recent Form 4, priced at the 2022-12-01 close. 1 holding could not be priced and is excluded from the total.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| EMMA | BUY | 2022-11-03 | 2022-12-01 | $0.40 | $21K | N/A | N/A | N/A |
| EMMA | BUY | 2022-10-31 | 2022-11-03 | $0.44 | $12K | N/A | N/A | N/A |
| EMMA | BUY | 2022-10-24 | 2022-10-31 | $0.28 | $19K | N/A | N/A | N/A |
| EMMA | BUY | 2022-10-19 | 2022-10-24 | $0.17 | $11K | N/A | N/A | N/A |
| EMMA | BUY | 2022-10-17 | 2022-10-19 | $0.19 | $9K | N/A | N/A | N/A |
| EMMA | BUY | 2022-10-13 | 2022-10-17 | $0.18 | $17K | N/A | N/A | N/A |
| EMMA | BUY | 2022-10-11 | 2022-10-13 | $0.08 | $13K | N/A | N/A | N/A |
| EMMA | BUY | 2022-09-26 | 2022-10-12 | $0.11 | $20K | N/A | N/A | N/A |
| EMMA | BUY | 2022-05-20 | 2022-06-02 | $0.49 | $3K | N/A | N/A | N/A |
| EMMA | BUY | 2022-05-09 | 2022-05-19 | $0.41 | $10K | N/A | N/A | N/A |
| EMMA | BUY | 2022-02-28 | 2022-03-02 | $1.49 | $80K | N/A | N/A | N/A |
| EMMA | BUY | 2022-02-24 | 2022-02-28 | $1.42 | $23K | N/A | N/A | N/A |
| EMMA | BUY | 2022-02-18 | 2022-02-23 | $1.44 | $28K | N/A | N/A | N/A |
| EMMA | BUY | 2022-02-16 | 2022-02-18 | $1.44 | $11K | N/A | N/A | N/A |
| EMMA | BUY | 2022-02-14 | 2022-02-16 | $1.45 | $17K | N/A | N/A | N/A |
| EMMA | BUY | 2022-02-09 | 2022-02-11 | $1.46 | $44K | N/A | N/A | N/A |
| EMMA | BUY | 2022-02-07 | 2022-02-09 | $1.48 | $13K | N/A | N/A | N/A |
| EMMA | BUY | 2022-02-03 | 2022-02-07 | $1.42 | $19K | N/A | N/A | N/A |
| EMMA | BUY | 2021-12-28 | 2022-01-03 | $1.57 | $28K | N/A | N/A | N/A |
| EMMA | BUY | 2021-12-22 | 2021-12-28 | $1.48 | $11K | N/A | N/A | N/A |
| EMMA | BUY | 2021-12-17 | 2021-12-22 | $1.50 | $16K | N/A | N/A | N/A |
| EMMA | BUY | 2021-12-10 | 2021-12-17 | $1.53 | $15K | N/A | N/A | N/A |
| EMMA | BUY | 2021-12-06 | 2021-12-10 | $1.58 | $10K | N/A | N/A | N/A |
| EMMA | BUY | 2021-12-02 | 2021-12-06 | $1.53 | $7K | N/A | N/A | N/A |
| EMMA | BUY | 2021-11-30 | 2021-12-02 | $1.54 | $64K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.